(Q42602432)

English

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

scientific article published on 24 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Norah Palmateer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Matthew Hickman

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Peter Vickerman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sharon J Hutchinson

2

object named as

Sharon Hutchinson

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Noel Craine

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Avril Taylor

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Daniela De Angelis

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sheila Cameron

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

John Parry

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Margaret Lyons

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

David Goldberg

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Elizabeth Allen

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

0 references

publication date

24 August 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1978-1988

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21615585%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

The burden of hepatitis C in England

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Substitution treatment of injecting opioid users for prevention of HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Effectiveness of needle-exchange programmes for prevention of HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Probable Inference, the Law of Succession, and Statistical Inference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Estimating the prevalence of ex-injecting drug use in the population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03515.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42602432&oldid=1653004512"